Twenty-four seven
7074
Alpico Holdings
297A
Branding Technology
7067
Estore
4304
Axel Mark
3624
JP Stock MarketDetailed Quotes
4884 Kringle Pharma
- 835
- +33+4.11%
20min DelayMarket Closed Dec 27 15:30 JST
5.69BMarket Cap-7.06P/E (Static)
845High798Low99.20KVolume798Open802Pre Close82.13MTurnover132852wk High2.08%Turnover Ratio6.81MShares39452wk Low-118.21EPS TTM3.98BFloat Cap1780Historical HighLossP/E (Static)4.76MShs Float394Historical Low-118.21EPS LYR5.86%Amplitude--Dividend TTM2.70P/B100Lot Size--Div YieldTTM
About Kringle Pharma Company
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases.
Company Profile
Symbol4884
Company NameKringle Pharma
Founded2001-12-21
MarketTSE Growth
Fiscal Year Ends09-30
Address7-7-15 Saitoasagi 207 Saito Bio-Incubator
Zip Code567-0085
Phone072-641-8739
Websitewww.kringle-pharma.com
Company Executives
- Name
- Position
- Salary
- Yoshiyuki Kayano
- Director and Reliability Assurance Manager
- --
- Yoshikazu Adachi
- Representative Director and President
- --
- Tomoho Masataku
- Director
- --
- Koichi Murakami
- Director and Director of Business Administration
- --
- Daima Hayata
- Director, Director of Pharmaceutical Development and Director of Pharmaceutical Affairs
- --
- Masato Fukui
- Independent Director
- --
- Koichiro Yoshino
- Independent Director
- --